Hangzhou Tigermed Consulting Co.Ltd(300347) independent director
Independent opinions on matters related to the 21st Meeting of the Fourth Board of directors of the company are in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and the rules for independent directors of listed companies As an independent director of Hangzhou Tigermed Consulting Co.Ltd(300347) (hereinafter referred to as “the company”), the relevant provisions of laws, regulations, normative documents such as the Listing Rules of Shenzhen Stock Exchange on the gem and the self regulatory guidelines for companies listed on the Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on the gem, as well as the articles of association of Hangzhou Tigermed Consulting Co.Ltd(300347) , We hereby express the following independent opinions on the matters involved in the relevant proposals deliberated and adopted at the 21st Meeting of the Fourth Board of directors of the company:
1、 Independent opinions on share repurchase plan of the company
1. The review procedure of this share repurchase complies with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the rules for share repurchase of listed companies and other relevant provisions, and the voting procedure of the board meeting to review this matter is legal and compliant.
2. The repurchased shares will be used for the implementation of the equity incentive plan or employee stock ownership plan. There is no situation that damages the interests of the listed company and all shareholders, and there is no situation that employees are forced to participate in the company’s equity incentive plan or employee stock ownership plan by means of apportionment, forced distribution, etc.
3. This share repurchase can further enhance the investment value of the company, help maintain the secondary market price, protect the interests of investors, enhance investors’ confidence in the company and maintain the company’s capital market image.
4. The share repurchase fund comes from the company’s own funds or self raised funds. The repurchase price is fair and reasonable, which will not affect the normal development of the company’s main business and will not damage the legitimate rights and interests of the company’s shareholders.
Therefore, our independent directors agree to the company’s plan of repurchasing the company’s shares for equity incentive plan or employee stock ownership plan.
(no text below)
Independent director: Yang Bo, Zheng Biyun, Liao Qiyu February 14, 2002
